Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Journal of Cellular and Molecular Medicine · 2025-01 · 29 (2)
DOI: 10.1111/jcmm.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 17.01.2025. Verfasst von Ceyhun Toruntay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Turkiye. Hauptthemen laut MEDLINE: Nanoparticles, Breast Neoplasms, Polylactic Acid-Polyglycolic Acid Copolymer, RNA, Small Interfering. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yildiz Teknik Üniversitesi.
Abstract (Originalsprache)
siRNA‐loaded nanoparticles open new perspectives for cancer treatment. MAPK6 is upregulated in breast cancer and is involved in cell growth, differentiation and cell cycle regulation. Herein, we aimed to investigate the anticancer effects of MAPK6 knockdown by using MAPK6 siRNA‐loaded PLGA nanoparticles (siMAPK6‐PLGA‐NPs) in MCF‐7 breast cancer cells. After the synthesis and characterisation of nanoparticles, treatment concentrations were determined with cytotoxicity assay. Subsequently, MAPK6 knockdown and anticancer effects of siMAPK6‐PLGA‐NPs were evaluated by in vitro assays. siMAPK6‐PLGA‐NPs have been determined to suppress MAPK6 expression efficiently. In vitro studies revealed that siMAPK6‐PLGA‐NPs significantly reduced the migration, proliferation and colony‐forming ability and enhanced the apoptosis in MCF‐7 cells. Taken together, siMAPK6‐PLGA‐NPs exhibited robust and promising anticancer effects against MCF‐7 cells. Our findings demonstrated that siRNA‐loaded PLGA nanoparticles have great potential for breast cancer treatment and MAPK6 gene may be the therapeutic target in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Turkiye.
- Department of Molecular Biology and Genetics, Graduate School of Science and Engineering, Yildiz Technical University, Istanbul, Turkiye.
- Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Yildiz Technical University, Istanbul, Turkiye.
- Department of Genetics, Institute of Health Sciences, Istanbul University, Istanbul, Turkiye.
- Department of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.
- Department of Neurogenetics, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, Istanbul, Turkiye.
ORCID-Profile: Ceyhun Toruntay, Fatma Sayan Poyraz, Seda Susgun, Emrah Yucesan, Banu Mansuroglu
Förderung
- Yildiz Teknik Üniversitesi
Zitieren
APA
Toruntay, C., Poyraz, F. S., Susgun, S., Yucesan, E., & Mansuroglu, B. (2025). Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer. Journal of Cellular and Molecular Medicine, 29(2). https://doi.org/10.1111/jcmm.70309
Vancouver
Toruntay C, Poyraz FS, Susgun S, Yucesan E, Mansuroglu B. Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer. Journal of Cellular and Molecular Medicine. 2025;29(2). doi:10.1111/jcmm.70309
BibTeX
@article{Toruntay2025,
author = {Toruntay, Ceyhun and Poyraz, Fatma Sayan and Susgun, Seda and Yucesan, Emrah and Mansuroglu, Banu},
title = {Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {2},
doi = {10.1111/jcmm.70309}
}
EUVIMED